<p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）在周三发布给客户和投资者的研究报告中，皇家银行的股票研究分析师将其目标价格从 525.00 美元上调至 555.00 美元。该券商目前对该股票给予 “跑赢大盘” 的评级。皇家银行的目标价格表明，相较于公司当前价格，存在 14.73% 的潜在上涨空间。</p>
<ul>
<li>这个 ETF 证明了医疗保健反弹是真实的</li>
</ul>
<p>其他几位研究分析师也最近对该股票发表了看法。富国银行将 HCA Healthcare 的目标价格从 431.00 美元上调至 452.00 美元，并在 1 月 7 日的报告中给予公司 “持平” 的评级。雷蒙德·詹姆斯金融在 10 月 27 日的报告中设定了 HCA Healthcare 的目标价格为 525.00 美元。美国银行在 10 月 27 日的报告中将 HCA Healthcare 的目标价格从 430.00 美元上调至 470.00 美元，并给予该股票 “中性” 的评级。高盛集团在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价格从 470.00 美元上调至 520.00 美元，并给予该股票 “买入” 的评级。最后，Cantor Fitzgerald 在周三的报告中将 HCA Healthcare 的目标价格从 525.00 美元上调至 588.00 美元，并给予该股票 “超配” 的评级。十五位研究分析师对该股票给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价格为 509.81 美元。</p>
<p>获取 <strong>HCA Healthcare</strong> 警报：</p>
<p><strong>查看我们关于 HCA 的最新研究报告</strong></p>
<h2>HCA Healthcare 股票表现</h2>
<ul>
<li>MarketBeat 周报 – 07/28 - 08/01</li>
</ul>
<p>HCA 的股票在周三下跌 22.09 美元，达到 483.76 美元。该股票的交易量为 620,669 股，而其平均交易量为 1,086,955 股。该公司的市值为 1103.9 亿美元，市盈率为 18.68，市盈增长比率为 1.30，贝塔值为 1.36。HCA Healthcare 的 12 个月低点为 295.00 美元，12 个月高点为 527.55 美元。该公司的 50 日简单移动平均线为 480.84 美元，200 日简单移动平均线为 435.90 美元。</p>
<p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最后一次发布季度财报是在 1 月 27 日，报告显示该公司每股收益为 8.01 美元，超出市场共识预期的 7.37 美元，超出幅度为 0.64 美元。该公司季度收入为 195.1 亿美元，而市场共识预期为 196.7 亿美元。HCA Healthcare 的股本回报率为负的 792.25%，净利润率为 8.53%。该公司的季度收入较去年同期增长了 6.7%。在去年同期，该公司每股收益为 6.22 美元。HCA Healthcare 已将其 2026 财年的指导目标设定为 29.100-31.500 每股收益。分析师预计 HCA Healthcare 在当前财年将发布 24.98 每股收益。</p>
<h2>HCA Healthcare 内部活动</h2>
<ul>
<li>HCA Healthcare 能否复兴市场最疲软的行业？</li>
</ul>
<p>在相关消息中，执行副总裁 Michael R. Mcalevey 于 11 月 5 日出售了 3,892 股 HCA Healthcare 股票，交易价格为 473.79 美元，总价值为 1,843,990.68 美元。交易完成后，该执行副总裁在公司持有 3,487 股，价值约为 1,652,105.73 美元。此次交易代表其持股比例减少了 52.74%。该交易已在 SEC 的法律文件中披露，相关文件可通过此链接访问。内部人士持有公司 1.30% 的股票。</p>
<h2>机构投资者对 HCA Healthcare 的看法</h2>
<p>对冲基金和其他机构投资者最近调整了对该公司的持股。M&amp;T 银行在第四季度将其在 HCA Healthcare 的股份增加了 172.0%。M&amp;T 银行目前持有该公司 23,253 股股票，价值 10,856,000 美元，此前在该期间内购买了 14,703 股。华侨银行在第四季度购买了 HCA Healthcare 的新股份，价值 273,000 美元。Optas LLC 在第四季度将其在 HCA Healthcare 的持股增加了 32.1%。Optas LLC 目前持有该公司 1,004 股股票，价值 469,000 美元，此前在上个季度购买了 244 股。SageGuard Financial Group LLC 在第四季度购买了 HCA Healthcare 的新股份，价值约为 4,576,000 美元。最后，Evergreen Capital Management LLC 在第四季度将其在 HCA Healthcare 的持股增加了 129.6%。Evergreen Capital Management LLC 目前持有该公司 3,379 股股票，价值 1,578,000 美元。62.73% 的股票目前由对冲基金和其他机构投资者持有。</p>
<h2>HCA Healthcare 的关键新闻</h2>
<p>以下是本周影响 HCA Healthcare 的关键新闻故事：</p>
<ul>
<li>积极情绪：第四季度业绩超出预期且基本面稳健——HCA 报告每股收益为 8.01 美元，远超预期，得益于强劲的患者数量和每次入院的收入增长。这增强了对基本需求的信心。业绩超预期</li>
<li>积极情绪：宣布大规模回购——HCA 将其股票回购计划增加了 100 亿美元，明确的资本回报承诺支持每股收益和股权估值。100 亿美元回购</li>
<li>积极情绪：股息增加——HCA 将季度股息提高了 8.3%，表明对现金流的信心，并向股东返还更多资本。股息增加</li>
<li>积极情绪：分析师升级/目标价上调——德意志银行和 Truist 分别将目标价上调至 558 美元和 546 美元，并维持买入评级，提供了短期看涨信号。分析师目标价上调</li>
<li>中性情绪：2026 年指引喜忧参半——HCA 给出的每股收益指引为 29.10–31.50 美元（大致符合市场预期），收入指引为 765 亿美元–800 亿美元（略高于共识），留有对增长与利润率轨迹的解读空间。指引</li>
<li>中性情绪：运营效率目标——管理层强调了一项 4 亿美元的成本节约计划和旨在抵消压力的韧性举措；执行情况将决定影响。成本节约</li>
<li>消极情绪：政策逆风——HCA 指出可能受到 ACA 交换保费税收抵免和医疗补助变更的影响（报告称影响在 6 亿美元至 10 亿美元以上），为 2026 年的现金流带来不确定性。政策逆风</li>
<li>消极情绪：第四季度收入略低于市场预期——收入略低于共识，结合政策风险，可能对短期增长预期造成压力。收入未达预期</li>
<li>消极情绪：估值/峰值利润率担忧——一些分析师警告称，利润率和回购推动的每股收益增长可能接近峰值，认为估值现在已充分反映了大部分上行空间。估值风险</li>
</ul>
<h2>关于 HCA 医疗保健</h2>
<p>(获取免费报告)</p>
<p>HCA 医疗保健是一家总部位于田纳西州纳什维尔的营利性医疗设施运营商。公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，通过有机扩张和收购成长为大型住院和门诊服务提供商。</p>
<p>公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们认为比 HCA 医疗保健更好的股票</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>美国的下一个权力举动从地下开始</li>
<li>你的签名缺失——在为时已晚之前采取行动</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>1933 年的退款：特朗普的重置可能创造即时财富</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 HCA 医疗保健吗？</h2>
<p>在考虑 HCA 医疗保健之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 HCA 医疗保健并不在名单上。</p>
<p>虽然 HCA 医疗保健目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

标普医疗保健服务 ETF - SPDR

医疗业 ETF - Vanguard

医疗业 ETF - SPDR

美国医疗保健供应商 ETF - iShares

标普全球医疗股指数 ETF - iShares

HCA控股

<p>加拿大皇家银行将 HCA Healthcare（纽约证券交易所代码：HCA）的目标股价从 525 美元上调至 555 美元，维持 “跑赢大盘” 的评级。这表明与当前价格相比，潜在上涨幅度为 14.73%。其他分析师也提高了他们的目标价，市场共识目标价为 509.81 美元。HCA 的股票最近交易价格为 483.76 美元，市值为 1103.9 亿美元。该公司报告了上一季度每股收益为 8.01 美元，超出预期，并已将 2026 财年的指导目标设定为每股收益 29.100-31.500 美元</p>

<p>HCA Healthcare (NYSE:HCA - Get Free Report) had its target price upped by equities research analysts at Royal Bank Of Canada from $525.00 to $555.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an &#34;outperform&#34; rating on the stock. Royal Bank Of Canada's target price indicates a potential upside of 14.73% from the company's current price.</p>
<div class="lb-trans"><p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）在周三发布给客户和投资者的研究报告中，皇家银行的股票研究分析师将其目标价格从 525.00 美元上调至 555.00 美元。该券商目前对该股票给予 “跑赢大盘” 的评级。皇家银行的目标价格表明，相较于公司当前价格，存在 14.73% 的潜在上涨空间。</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>这个 ETF 证明了医疗保健反弹是真实的</li>
</ul>
</div><p>Several other research analysts have also recently weighed in on the stock. Wells Fargo &amp; Company boosted their price objective on shares of HCA Healthcare from $431.00 to $452.00 and gave the company an &#34;equal weight&#34; rating in a report on Wednesday, January 7th. Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a report on Monday, October 27th. Bank of America raised their target price on HCA Healthcare from $430.00 to $470.00 and gave the stock a &#34;neutral&#34; rating in a report on Monday, October 27th. The Goldman Sachs Group raised their price objective on HCA Healthcare from $470.00 to $520.00 and gave the stock a &#34;buy&#34; rating in a research note on Monday, October 27th. Finally, Cantor Fitzgerald increased their target price on shares of HCA Healthcare from $525.00 to $588.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday. Fifteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $509.81.</p>
<div class="lb-trans"><p>其他几位研究分析师也最近对该股票发表了看法。富国银行将 HCA Healthcare 的目标价格从 431.00 美元上调至 452.00 美元，并在 1 月 7 日的报告中给予公司 “持平” 的评级。雷蒙德·詹姆斯金融在 10 月 27 日的报告中设定了 HCA Healthcare 的目标价格为 525.00 美元。美国银行在 10 月 27 日的报告中将 HCA Healthcare 的目标价格从 430.00 美元上调至 470.00 美元，并给予该股票 “中性” 的评级。高盛集团在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价格从 470.00 美元上调至 520.00 美元，并给予该股票 “买入” 的评级。最后，Cantor Fitzgerald 在周三的报告中将 HCA Healthcare 的目标价格从 525.00 美元上调至 588.00 美元，并给予该股票 “超配” 的评级。十五位研究分析师对该股票给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价格为 509.81 美元。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>HCA Healthcare</strong> 警报：</p>
</div><p><strong>Check Out Our Latest Research Report on HCA</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 HCA 的最新研究报告</strong></p>
</div><h2>HCA Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>HCA Healthcare 股票表现</h2>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 07/28 - 08/01</li>
</ul>
</div><p>Shares of HCA traded down $22.09 on Wednesday, reaching $483.76. The stock had a trading volume of 620,669 shares, compared to its average volume of 1,086,955. The firm has a market capitalization of $110.39 billion, a price-to-earnings ratio of 18.68, a price-to-earnings-growth ratio of 1.30 and a beta of 1.36. HCA Healthcare has a 12-month low of $295.00 and a 12-month high of $527.55. The company has a 50-day simple moving average of $480.84 and a 200-day simple moving average of $435.90.</p>
<div class="lb-trans"><p>HCA 的股票在周三下跌 22.09 美元，达到 483.76 美元。该股票的交易量为 620,669 股，而其平均交易量为 1,086,955 股。该公司的市值为 1103.9 亿美元，市盈率为 18.68，市盈增长比率为 1.30，贝塔值为 1.36。HCA Healthcare 的 12 个月低点为 295.00 美元，12 个月高点为 527.55 美元。该公司的 50 日简单移动平均线为 480.84 美元，200 日简单移动平均线为 435.90 美元。</p>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The company had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm's quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts expect that HCA Healthcare will post 24.98 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最后一次发布季度财报是在 1 月 27 日，报告显示该公司每股收益为 8.01 美元，超出市场共识预期的 7.37 美元，超出幅度为 0.64 美元。该公司季度收入为 195.1 亿美元，而市场共识预期为 196.7 亿美元。HCA Healthcare 的股本回报率为负的 792.25%，净利润率为 8.53%。该公司的季度收入较去年同期增长了 6.7%。在去年同期，该公司每股收益为 6.22 美元。HCA Healthcare 已将其 2026 财年的指导目标设定为 29.100-31.500 每股收益。分析师预计 HCA Healthcare 在当前财年将发布 24.98 每股收益。</p>
</div><h2>Insider Activity at HCA Healthcare</h2>
<div class="lb-trans"><h2>HCA Healthcare 内部活动</h2>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare 能否复兴市场最疲软的行业？</li>
</ul>
</div><p>In related news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.30% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁 Michael R. Mcalevey 于 11 月 5 日出售了 3,892 股 HCA Healthcare 股票，交易价格为 473.79 美元，总价值为 1,843,990.68 美元。交易完成后，该执行副总裁在公司持有 3,487 股，价值约为 1,652,105.73 美元。此次交易代表其持股比例减少了 52.74%。该交易已在 SEC 的法律文件中披露，相关文件可通过此链接访问。内部人士持有公司 1.30% 的股票。</p>
</div><h2>Institutional Investors Weigh In On HCA Healthcare</h2>
<div class="lb-trans"><h2>机构投资者对 HCA Healthcare 的看法</h2>
</div><p>Hedge funds and other institutional investors have recently modified their holdings of the business. M&amp;T Bank Corp increased its stake in HCA Healthcare by 172.0% in the fourth quarter. M&amp;T Bank Corp now owns 23,253 shares of the company's stock worth $10,856,000 after purchasing an additional 14,703 shares during the period. OVERSEA CHINESE BANKING Corp Ltd purchased a new stake in HCA Healthcare during the fourth quarter worth $273,000. Optas LLC boosted its position in HCA Healthcare by 32.1% during the fourth quarter. Optas LLC now owns 1,004 shares of the company's stock valued at $469,000 after purchasing an additional 244 shares in the last quarter. SageGuard Financial Group LLC bought a new position in HCA Healthcare in the fourth quarter worth about $4,576,000. Finally, Evergreen Capital Management LLC grew its position in shares of HCA Healthcare by 129.6% in the 4th quarter. Evergreen Capital Management LLC now owns 3,379 shares of the company's stock worth $1,578,000 after buying an additional 1,907 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近调整了对该公司的持股。M&amp;T 银行在第四季度将其在 HCA Healthcare 的股份增加了 172.0%。M&amp;T 银行目前持有该公司 23,253 股股票，价值 10,856,000 美元，此前在该期间内购买了 14,703 股。华侨银行在第四季度购买了 HCA Healthcare 的新股份，价值 273,000 美元。Optas LLC 在第四季度将其在 HCA Healthcare 的持股增加了 32.1%。Optas LLC 目前持有该公司 1,004 股股票，价值 469,000 美元，此前在上个季度购买了 244 股。SageGuard Financial Group LLC 在第四季度购买了 HCA Healthcare 的新股份，价值约为 4,576,000 美元。最后，Evergreen Capital Management LLC 在第四季度将其在 HCA Healthcare 的持股增加了 129.6%。Evergreen Capital Management LLC 目前持有该公司 3,379 股股票，价值 1,578,000 美元。62.73% 的股票目前由对冲基金和其他机构投资者持有。</p>
</div><h2>Key HCA Healthcare News</h2>
<div class="lb-trans"><h2>HCA Healthcare 的关键新闻</h2>
</div><p>Here are the key news stories impacting HCA Healthcare this week:</p>
<div class="lb-trans"><p>以下是本周影响 HCA Healthcare 的关键新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Q4 earnings beat and solid fundamentals — HCA reported EPS of $8.01, well above expectations, driven by strong patient volumes and higher revenue per admission. This underpins confidence in underlying demand. Earnings Beat</li>
<li>Positive Sentiment: Big buyback announced — HCA added $10 billion to its share repurchase program, a clear capital-return commitment that supports EPS and equity valuation. $10B Buyback</li>
<li>Positive Sentiment: Dividend increase — HCA raised its quarterly dividend by 8.3%, signaling confidence in cash flow and returning more capital to shareholders. Dividend Raise</li>
<li>Positive Sentiment: Analyst upgrades/price-target increases — Deutsche Bank and Truist raised price targets (to $558 and $546 respectively) and maintain buy ratings, providing a near-term bullish signal. Analyst PT Raises</li>
<li>Neutral Sentiment: 2026 guidance is mixed — HCA gave EPS guidance of $29.10–$31.50 (around Street estimates) and revenue guidance of $76.5B–$80B (slightly wide of consensus), leaving room for interpretation on growth vs. margin trajectory. Guidance</li>
<li>Neutral Sentiment: Operational efficiency targets — Management highlighted a $400M cost-savings plan and resiliency initiatives intended to offset pressures; execution will determine impact. Cost Savings</li>
<li>Negative Sentiment: Policy headwinds — HCA flagged potential hits from ACA exchange premium tax credit and Medicaid changes (reports cite $600M–$1B+ impact), creating uncertainty for 2026 cash flow. Policy Headwinds</li>
<li>Negative Sentiment: Revenue slightly missed Street in Q4 — Revenue was modestly below consensus, which, combined with policy risks, may weigh on near-term growth expectations. Revenue Miss</li>
<li>Negative Sentiment: Valuation/peak-margin concerns — Some analysts caution margins and buyback-fueled EPS gains may be approaching a peak, arguing valuation now fully reflects much of the upside. Valuation Risks</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：第四季度业绩超出预期且基本面稳健——HCA 报告每股收益为 8.01 美元，远超预期，得益于强劲的患者数量和每次入院的收入增长。这增强了对基本需求的信心。业绩超预期</li>
<li>积极情绪：宣布大规模回购——HCA 将其股票回购计划增加了 100 亿美元，明确的资本回报承诺支持每股收益和股权估值。100 亿美元回购</li>
<li>积极情绪：股息增加——HCA 将季度股息提高了 8.3%，表明对现金流的信心，并向股东返还更多资本。股息增加</li>
<li>积极情绪：分析师升级/目标价上调——德意志银行和 Truist 分别将目标价上调至 558 美元和 546 美元，并维持买入评级，提供了短期看涨信号。分析师目标价上调</li>
<li>中性情绪：2026 年指引喜忧参半——HCA 给出的每股收益指引为 29.10–31.50 美元（大致符合市场预期），收入指引为 765 亿美元–800 亿美元（略高于共识），留有对增长与利润率轨迹的解读空间。指引</li>
<li>中性情绪：运营效率目标——管理层强调了一项 4 亿美元的成本节约计划和旨在抵消压力的韧性举措；执行情况将决定影响。成本节约</li>
<li>消极情绪：政策逆风——HCA 指出可能受到 ACA 交换保费税收抵免和医疗补助变更的影响（报告称影响在 6 亿美元至 10 亿美元以上），为 2026 年的现金流带来不确定性。政策逆风</li>
<li>消极情绪：第四季度收入略低于市场预期——收入略低于共识，结合政策风险，可能对短期增长预期造成压力。收入未达预期</li>
<li>消极情绪：估值/峰值利润率担忧——一些分析师警告称，利润率和回购推动的每股收益增长可能接近峰值，认为估值现在已充分反映了大部分上行空间。估值风险</li>
</ul>
</div><h2>About HCA Healthcare</h2>
<div class="lb-trans"><h2>关于 HCA 医疗保健</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.</p>
<div class="lb-trans"><p>HCA 医疗保健是一家总部位于田纳西州纳什维尔的营利性医疗设施运营商。公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，通过有机扩张和收购成长为大型住院和门诊服务提供商。</p>
</div><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p>
<div class="lb-trans"><p>公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>America's Next Power Move Starts Underground</li>
<li>Your Signature Is Missing – Act Before It’s Too Late</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 HCA 医疗保健更好的股票</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>美国的下一个权力举动从地下开始</li>
<li>你的签名缺失——在为时已晚之前采取行动</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>1933 年的退款：特朗普的重置可能创造即时财富</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 HCA 医疗保健吗？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 HCA 医疗保健之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 HCA 医疗保健并不在名单上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 HCA 医疗保健目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

加拿大皇家银行预测 HCA Healthcare（纽约证券交易所代码：HCA）股票将出现强劲的价格上涨